chos también requerirán de RMc para confirmarlos.
Front Neurol Neurosci 2014; 33:69–81 9. Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in
CONCLUSIONES El ACV cardioembólico es una causa de muerte creciente en la mayor parte de la población mundial y será por muchos años la primer causa de discapacidad. Aún hay mucho camino por recorrer en el diagnóstico de un porcentaje importante de casos, lo que genera dudas o errores en la prevención secundaria. Sus devastadoras consecuencias obligan a un notable esfuerzo en el auxilio y tratamiento precoz. Existe una estrecha relación entre el corazón y el cerebro en este grupo de pacientes que significará en un futuro inmediato un gran impulso para el desarrollo de la Neuro-cardiología, mostrando un gran ejemplo de la actividad médica multidisciplinaria.
1990–2013: The GBD 2013 Study. Neuroepidemiology 2015; 45:161–176 10. Sánchez-Larsen A, García-García J, Ayo-Martín O, et al. Has the aetiology of ischaemic stroke changed in the past decades? Analysis and comparison of data from current and historical stroke databases. Neurología. 2016. http:// dx.doi.org/10.1016/j.nrl.2016.07.003 11. Andersen KK, Andersen ZJ, Olsen TS. Age and gender specific prevalence of cardiovascular risk factors in 40102 patients with first ever ischemic stroke. A nationwide Danish study. Stroke. 2010; 41:2768—74 12. Ziegler PD, Glotzer TV, Daoud EG, et al. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol. 2012; 110:1309—14 13. Kishore A, Vail A, Majid A, et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic at-
REFERENCIAS
tack: A systematic review and meta-analysis. Stroke. 2014;
1. World Health Organization. The atlas of heart disease and stroke. Geneva, Switzerland: World Health Organization; 2014. Available from: http://www.who.int/cardiovascular_diseases/resources/atlas/en/.
45:520—6 14. Dhamoon MS, Sciacca RR, Rundek T, et al. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology. 2006; 66:641–6
2. Go AS, Mozaffarian D, Roger VL, et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014; 129:e28–e292.
15. Kernan WN, Viscoli CM, Brass LM, et al. The Stroke Prognosis Instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and non disabling ischemic stroke. Stroke. 2000; 31:456–62 16. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurren-
3. Kleindorfer D, Panagos P, Pancioli A, et al. Incidence and short-term prognosis of transient ischemicattack in a population-based study. Stroke. 2005; 36:720–3
ce by subtypeof ischemic stroke in population-based incidence studies. Neurology.2004; 62:569–573 17. Hillen T, Coshall C, Tilling K, et al. Causeof stroke recu-
4. Tsai CF, Anderson N, Thomas B, Sudlow CL. Risk factors for ischemic stroke and its subtypes in Chinese vs. Caucasians: Systematic review and meta-analysis. Int J Stroke. 2015; 10:485-93
rrence is multifactorial: patterns, risk factors, and outcomesof stroke recurrence in the South London Stroke Register. Stroke. 2003; 34:1457–1463 18. Kernan WN, Ovbiagele B, Black HR, et al; on behalf of
5. Tibæk M, Dehlendorff C, Jørgensen HS, et al. Increasing Incidence of Hospitalization for Stroke and Transient Ischemic Attack in Young Adults: A Registry-Based Study. J Am Heart Assoc. 2016;5. pii: e003158.
the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke
6. Johnston SC, Gress DR, Browner WS, Sidney S. Shortterm prognosis after emergency department diagnosis of TIA. JAMA. 2000; 284:2901–6
and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45:2160-2236
7. Strom JO, Tavosian A, Appelros P. Cardiovascular risk factors and TIA characteristics in 19,872 Swedish TIA patients. Acta Neurol Scand. 2016; 134:427-433
19. Hart RG, Diener HC, Coutts SB, et al. Cryptogenic Stroke/ ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct.
8. Kokubo Y. Epidemiology of transient ischemic attack.
Lancet Neurol. 2014; 13:429–438.
33 - diagnosticojournal.com
